Timothy Ko

CEO
Entheon BioMedical
(OTCMKTS: ENTBF) (CSE: ENBI)

Timothy has a background of leading private ventures in the Service Sector, Investor Relations, Retail and Technology sectors. With a professional emphasis on disruptive technologies that challenge the status quo, Timothy’s passion for the psychedelic space is shaped by firsthand knowledge of the shortcomings of current mental health and addiction treatment options, and through his exposure to psychedelics, which he credits with saving his life.